Skip to content
Keratin 14 Filamentfärbung von Keratinozyten in grün, mit Plasmid transfizierte Zelle in rot 20x

Flexible funding needed?

Ad-hoc grants

This channel allows EB-ResNet and its potential grantholders to remain flexible and to respond in a timely manner to opportunities that arise, such as co-funding options, immediate need for funds, novel project ideas, or proof-of-concept projects.

Academic researchers, clinicians and also industry may approach EB-ResNet outside the scheduled research-proposal calls if there is an urgent need or a co-funding opportunity arises. This funding channel is only available while no research grant call is open. For example, an international or national funding scheme, a company or another patient group may offer funding schemes that also invite co-funding. Proposals more appropriate to scheduled research grant calls or industry co-funding, will be redirected.

Project scope 'Ad-hoc grants'

  • Fundamental to clinical research projects in EB
  • Quick funding/co-funding to respond to an opportunity arising in fundamental to preclinical research or a proof-of-concept project in EB
  • Lead applicant: researchers, clinicians, and/or industry partners (cooperation with industry welcome and possible)
  • Project duration: up to 12 months
  • Funding: up to EUR 100,000.00 p.a.

Application process

The application process has two steps. Informal application is done via a letter of interest (LOI) to

Please bear in mind that this funding channel is only available while no research grant is open - check under Research grants.

You will be informed whether your project fits into our funding scheme and if so, sent a link to our Grant Management online Application form.

General information: application and funding process

Funded ad-hoc grants

Ad-hoc grants


Project lead



Duration Research area EB-type Funder(s)
Ad-hoc 2020/2 Dr. Mattew Caley Queen Mary University London, UK 2 years Small molecules Junctional

DEBRA Austria

LifeArc Philantrophic Fund (UK)

Ad-hoc 2020/1

Prof. Dennis Roop,

Dr. Ganna Bilousova

University of Colorado, Denver,


3 years




DEBRA Austria

Vlinderkindje (B)

Ad-hoc 2019/1 Dr. Thomas Magin

University of Leipzig, Germany

1 year

Fever in EB



DEBRA Austria

Tove Bruce (Sweden)

Ad-hoc 2019/2

DDr. Gudrun Salamon


Sigmund Freud University, Austria 18 months

Quality of life,





DEBRA Austria
Ad-hoc 2017/1

Dr. Alexander Nyström,

Dr. Leena Bruckner-Tuderman


University of Freiburg - Medical Center,

Departement of Dermatology, Germany

1 year



Dystrophic DEBRA Austria
Ad-hoc 2016/1 Prof. Dennis Roop

University of Colorado, Denver,


2 years Preclinical Simplex

DEBRA Austria

Vlinderkindje (B)


Contact for Ad-hoc grants

Portraitfoto von Gaston Sendin

Gaston Sendin, PhD

Head of Research
Back to main navigation
This website uses cookies to give you the best possible service. By using this website, you agree to the use of cookies. Detailed information can be found in our privacy policy .